Skip to content

RETINOP

Active Private limited companyfounded 2008active for 17 yearsRue du Dépôt 22B, 6120 Ham-sur-Heure-NalinnesKBO/BCE: BE 0808.439.768

Lifetime

17 annual accounts with figures on one time axis
peak of €612,428 in 2025
€612,428▲ 94.2%
lowest -€74,879 in 2017
€340,163▲ 132%
peak of €674,881 in 2025
€674,881▲ 22.6%
€446,291▲ 12.0%
Board2 names since 2014
1 director
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Gross margin from €315,295 to €612,428Result from €146,880 to €340,163Dividend €215,721Equity from €550,439 to €674,881

Key points

from the 2025 annual accounts

Equity

€674,881 ▲ 22.6%
550,4392024+340,163Profit-215,721Dividend674,8812025

RETINOP paid out €215,721 in dividends. That is 63% of the 2025 profit.

Result

€340,163 ▲ 132%
€147,0002024€340,0002025

The result rose in 2025: different schema filed.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Eight of the last ten came late. The 2016 accounts came in latest, 60 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as RETINOP has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for RETINOP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • all the sharesdeed of 05-07-2023
Board & ownership

Recent changes

changes role from manager to sole director holds all the shares · General meeting of 27-06-2023 · Gazette deed
reappointed as director General meeting of 03-06-2020 · Gazette deed
Registered office moved from Loverval to Nalinnes The registered office moved from Allée des Templiers 41A 4.1 à 6280 Loverval to Rue du Dépôt 22B 6120 Nalinnes · Gazette deed
First establishment At the time the registered office was still in Loverval, Allée des Templiers 41A 4.1.
All 31 events

Official details

Source: KBO
Status
Active since 15-12-2008Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 2 activities
Establishment unit
2.362.233.0806120 Ham-sur-Heure-Nalinnes, registered on 15-05-2018
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €1.5mestimated
€1.1m▲ 18.1%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on RETINOP

RETINOP files the abbreviated format. That format states no turnover. The gross margin rose from €66,878 in 2009 to €612,428 in 2025.

The balance sheet grew most from 2010 to 2012 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about RETINOP

What is the company number of RETINOP?
The company number of RETINOP is 0808.439.768. The VAT number is the same number with BE in front: BE 0808.439.768.
Where is RETINOP based?
The registered office is at Rue du Dépôt 22B, 6120 Ham-sur-Heure-Nalinnes.Company details
What does RETINOP do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of RETINOP?
RETINOP is a private limited company (BV).
When was RETINOP founded?
RETINOP was founded on 15-12-2008.
Is RETINOP still active?
Yes, RETINOP is an active enterprise in the KBO register.
What is the turnover of RETINOP?
The turnover in financial year 2025 is about €1.5m. This figure is estimated from the gross margin of €612,428 and 2,135 comparable companies of the same size. It probably lies between €870,000 and €2.5m. It is a rough estimate.Financials
Is RETINOP profitable?
In financial year 2025, RETINOP made a profit of €340,163.
Where can I find the annual accounts of RETINOP?
RETINOP filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of RETINOP due?
RETINOP must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.